Afia Asamoah
About
Afia Asamoah is from San Francisco, California, United States. Afia works in the following industries: "Law Practice", "Internet", "Government Administration", "Biotechnology", "Medical Device", and "Venture Capital & Private Equity". Afia is currently Limited Partner at How Women Invest. In Afia's previous role as a Head of Legal, Google Health at Google, Afia worked in Palo Alto, California until Nov 2021. Prior to joining Google, Afia was a Senior Counsel, Legal, Regulatory, and Policy at Verily Life Sciences and held the position of Senior Counsel, Legal, Regulatory, and Policy. Prior to that, Afia was a Senior Counsel & Trust and Compliance Officer at Verily Life Sciences, based in Mountain View from Jul 2016 to Jul 2018. Afia started working as Senior Counsel at Verily Life Sciences in Mountain View, CA in Dec 2015. From Feb 2014 to Dec 2015, Afia was Product Counsel at Google, based in Mountain View, California. Prior to that, Afia was a Senior Associate at Covington & Burling LLP, based in New York, NY from Mar 2011 to Jan 2014. Afia started working as Special Assistant to the Principal Deputy Commissioner at Food and Drug Administration in Silver Spring, MD in May 2009.
You can find Afia Asamoah's email address at finalscout.com. FinalScout is a free professional database with over five hundred million business professional profiles and over two hundred million company profiles.
Afia Asamoah's current jobs
How Women Invest provides capital, mentoring, and a network of influential female leaders to support female startup founders, particularly women of color. https://www.howwomenlead.com/howwomeninvest
Afia Asamoah's past jobs
Member of health executive leadership team, leading global team of lawyers and compliance professionals that work with product teams building b2c and b2b medical software and AI enabled health products
Reporting to GC, lead team of product/data privacy lawyers, policy, information governance professionals that provide heealthcare law, data privacy and security, regulatory, and public policy support to Verily healthcare technology Product (HW and SW), Business, R&D, Clinical, and Marketing teams
Appointed by CEO as Verily's first Trust and Compliance Officer, developed policies and training materials, and presented to Alphabet Board of Directors (Audit Committee) on status of the program. Oversaw and guided Verily's spin out from Google as an independent company in October 2017
Built and lead the company's first team of product counsel Established Verily's healthcare compliance program Counseled business units developing a diverse portfolio of healthcare technology and AI products
Recruited as the first lawyer supporting product teams building health technology, and led first-ever licensing of Google patents around smart lens technology for Google-Alcon collaboration. Guided clinical and product development teams on contractual issues and medical device clinical trial regulations
Counseled pharmaceutical, biotechnology, and medical device companies, and advocated for those companies at FDA, on the full range of FDA issues involving clinical development, marketing approval, promotion, post marketing requirements, and obtaining and protecting market exclusivity for medical products. Guided investors and acquiring companies evaluate opportunities in the life sciences industry and conducted regulatory due diligence for those deals.
Guided FDA Commissioner, Principal Deputy Commissioner and senior FDA management on significant regulatory and policy matters across FDA device, drug, biologic, and food product areas. As leader of an agency-wide Transparency Initiative, I worked to improve the transparency and predictability of the FDA regulatory process to spur product innovation. Partnered with senior leaders and staff to develop the strategy for FDA enforcement activities and helped create the new FDA center to regulate tobacco products.
Guided pharmaceutical and medical device clients on matters including product approval, Hatch-Waxman Amendments, clinical trials, product promotion, fraud and abuse, and HIPPA compliance.
Drafted bench memoranda and published opinions on criminal and civil matters. Oversaw the judicial consent decree governing pretrial detainees at Rikers Island and drafted legislative language (signed into law July 2010) to amend section 702 of the New York State Corrections Law.
Provided research and management support to health policy leader for majority staff of Government Reform Committee. Drafted an oversight letter to government officials regarding conduct of international drug clinical trials and led staff briefing on FDA drug approval process and international HIV clinical trials.